Dyax Corp. (NASDAQ:DYAX) announced today that executive management will participate in the 2014 Leerink Global Healthcare Conference being held February 12-13, 2014 at the Waldorf Astoria in New York City. On Wednesday, February 12 at 11:05AM (ET), Gustav Christensen, President and Chief Executive Officer, will participate in a fireside chat to discuss the Company’s key value drivers – the KALBITOR® (ecallantide) business, DX-2930 and the Licensing and Funded Research Portfolio.
Help employers find you! Check out all the jobs and post your resume.
